Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.
Anthropic CEO Dario Amodei says artificial intelligence could trigger a biotech renaissance, accelerating breakthroughs in peptide drugs, CAR-T therapies, and programmable biology through AI-assisted ...
EIR Biopharma is hoping to bring in $17.1 million from an IPO on the New York Stock Exchange that could fund development of its preclinical eye disease drug. | EIR Biopharma is hoping to bring in $17.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results